JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB223890

INDY, DYRK1A/B inhibitor

Be the first to review this product! Submit a review

|

(2 Publications)

MW 235.3 Da, Purity >98%. Potent DYRK1A/B inhibitor (IC50 values are 0.23 and 0.24 μM for DYRK1B and DYRK1A respectively). Also inhibits DYRK2, DTRK4, CLK1, CLK4, casein kinase 1 and PIM1 (> 90% inhibition at 10 μM). Reverses aberrant tau-phosphorylation and rescues repressed calcineurin/NFAT signaling. Impairs the self-renewal capacity of neural stem cells and glioblastoma tumor-initiating cells.
1 Images
Chemical Structure - INDY, DYRK1A/B inhibitor (AB223890)
  • Chemical Structure

Lab

Chemical Structure - INDY, DYRK1A/B inhibitor (AB223890)

2D chemical structure image of ab223890, INDY, DYRK1A/B inhibitor

Key facts

Purity

>98%

Form

Solid

form

Molecular weight

235.3 Da

Molecular formula

C<sub>1</sub><sub>2</sub>H<sub>1</sub><sub>3</sub>NO<sub>2</sub>S

PubChem

69538603

Nature

Synthetic

Solubility

Soluble in DMSO to 100 mM

Biochemical name

CID 69538603

Biological description

Potent DYRK1A/B inhibitor (IC50 values are 0.23 and 0.24 μM for DYRK1B and DYRK1A respectively). Also inhibits DYRK2, DTRK4, CLK1, CLK4, casein kinase 1 and PIM1 (> 90% inhibition at 10 μM). Reverses aberrant tau-phosphorylation and rescues repressed calcineurin/NFAT signaling. Impairs the self-renewal capacity of neural stem cells and glioblastoma tumor-initiating cells.

Canonical smiles

CCN1C2=C(C=CC(=C2)O)SC1=CC(=O)C

InChi

InChI=1S/C12H13NO2S/c1-3-13-10-7-9(15)4-5-11(10)16-12(13)6-8(2)14/h4-7,15H,3H2,1-2H3

InChiKey

GCSZJMUFYOAHFY-UHFFFAOYSA-N

IUPAC Name

1-(3-ethyl-5-hydroxy-1,3-benzothiazol-2-ylidene)propan-2-one

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C

Product protocols

Publications (2)

Recent publications for all applications. Explore the full list and refine your search

The Journal of clinical investigation 123:2475-87 PubMed23635774

2013

Inhibition of DYRK1A destabilizes EGFR and reduces EGFR-dependent glioblastoma growth.

Applications

Unspecified application

Species

Unspecified reactive species

Natividad Pozo,Cristina Zahonero,Paloma Fernández,Jose M Liñares,Angel Ayuso,Masatoshi Hagiwara,Angel Pérez,Jose R Ricoy,Aurelio Hernández-Laín,Juan M Sepúlveda,Pilar Sánchez-Gómez

Nature communications 1:86 PubMed20981014

2010

Development of a novel selective inhibitor of the Down syndrome-related kinase Dyrk1A.

Applications

Unspecified application

Species

Unspecified reactive species

Yasushi Ogawa,Yosuke Nonaka,Toshiyasu Goto,Eriko Ohnishi,Toshiyuki Hiramatsu,Isao Kii,Miyo Yoshida,Teikichi Ikura,Hiroshi Onogi,Hiroshi Shibuya,Takamitsu Hosoya,Nobutoshi Ito,Masatoshi Hagiwara
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com